Women in Africa could soon access dapivirine ring, which reduces risk of HIV

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
Made of flexible silicone, the ring slowly releases dapivirine, an antiretroviral medicine, locally to the site of potential infection, with minimal absorption elsewhere in the body. Picture: Supplied
Made of flexible silicone, the ring slowly releases dapivirine, an antiretroviral medicine, locally to the site of potential infection, with minimal absorption elsewhere in the body. Picture: Supplied

NEWS

In a world starved of good news under the weight of the deadly and highly infectious Covid-19 coronavirus pandemic, the field of HIV prevention and women’s sexual reproductive health has reason to celebrate.

The dapivirine vaginal ring, designed to help address women’s unmet need for new methods to protect themselves from contracting HIV, could soon be available for use by women aged 18 and older in Africa. This after getting a nod of approval from the European Medicines Agency (EMA) on Friday.

Support independent journalism
Subscribe to News24 for just R75 per month to read all our investigative and in-depth journalism. You can cancel any time.
Subscribe
Already a subscriber? Sign in

E-Editions

Read the digital editions of City Press here.
Read now
Voting Booth
President Cyril Ramaphosa has praised outgoing Chief Justice Mogoeng Mogoeng for his outstanding leadership and service. Do you agree?
Please select an option Oops! Something went wrong, please try again later.
Results
He served well.
64% - 150 votes
He was too controversial
36% - 83 votes
Vote